3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
11
Thoracic
5
Gastrointestinal
5
Other
3
Lymphoid
3
Gynecologic
2
Genitourinary
2
CNS
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
874
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Hematologic Neoplasms
462
Leukemia, Lymphocytic, Chronic, B-Cell
388
Leukemia
328
Myelodysplastic Syndromes
324
Lymphoma
203
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Recurrence
136
Neoplasms
133
Leukemia, Myelomonocytic, Chronic
110
Burkitt Lymphoma
92
Lymphoma, Mantle-Cell
91
Lymphoma, Follicular
91
Lymphoma, Large B-Cell, Diffuse
88
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Leukemia, Biphenotypic, Acute
79
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
53
Leukemia, B-Cell
50
Anemia, Refractory, with Excess of Blasts
45
Leukemia, Myeloid, Chronic-Phase
40
Hematologic Diseases
37
Lymphoma, T-Cell
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled